annual SGA:
$0.00-$31.07M(-100.00%)Summary
- As of today (September 16, 2025), AKRO annual SGA is $0.00, with the most recent change of -$31.07 million (-100.00%) on December 31, 2024.
- During the last 3 years, AKRO annual SGA has fallen by -$19.13 million (-100.00%).
- AKRO annual SGA is now -100.00% below its all-time high of $31.07 million, reached on December 31, 2023.
Performance
AKRO SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly SGA:
$0.00-$11.31M(-100.00%)Summary
- As of today (September 16, 2025), AKRO quarterly SGA is $0.00, with the most recent change of -$11.31 million (-100.00%) on June 30, 2025.
- Over the past year, AKRO quarterly SGA has dropped by -$10.42 million (-100.00%).
- AKRO quarterly SGA is now -100.00% below its all-time high of $11.31 million, reached on March 31, 2025.
Performance
AKRO quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM SGA:
-$3.45B-$283.96M(-8.98%)Summary
- As of today (September 16, 2025), AKRO TTM SGA is -$3.45 billion, with the most recent change of -$283.96 million (-8.98%) on June 30, 2025.
- Over the past year, AKRO TTM SGA has dropped by -$3.48 billion (-9624.82%).
- AKRO TTM SGA is now -75416.10% below its all-time high of -$4.56 million.
Performance
AKRO TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Selling, general & administrative expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
AKRO Selling, general & administrative expenses Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -100.0% | -100.0% | -9624.8% |
3 y3 years | -100.0% | -100.0% | -10000.0% |
5 y5 years | -100.0% | -100.0% | -10000.0% |
AKRO Selling, general & administrative expenses Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -100.0% | at low | -100.0% | at low | -167.5% | at low |
5 y | 5-year | -100.0% | at low | -100.0% | at low | -531.6% | at low |
alltime | all time | -100.0% | at low | -100.0% | at low | <-9999.0% | at low |
AKRO Selling, general & administrative expenses History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Jun 2025 | - | $0.00(-100.0%) | $20.79M(-33.4%) |
Mar 2025 | - | $11.31M(>+9900.0%) | $31.20M(+6.9%) |
Dec 2024 | $0.00(-100.0%) | $0.00(-100.0%) | $29.19M(-22.5%) |
Sep 2024 | - | $9.47M(-9.1%) | $37.67M(+4.1%) |
Jun 2024 | - | $10.42M(+12.0%) | $36.19M(+8.3%) |
Mar 2024 | - | $9.30M(+9.7%) | $33.41M(+7.5%) |
Dec 2023 | $31.07M(+4.0%) | $8.48M(+6.3%) | $31.07M(+4.7%) |
Sep 2023 | - | $7.98M(+4.4%) | $29.69M(-9.2%) |
Jun 2023 | - | $7.64M(+9.7%) | $32.71M(+4.5%) |
Mar 2023 | - | $6.97M(-1.9%) | $31.30M(+4.8%) |
Dec 2022 | $29.87M(+56.2%) | $7.10M(-35.5%) | $29.87M(+8.6%) |
Sep 2022 | - | $11.00M(+76.6%) | $27.50M(+28.6%) |
Jun 2022 | - | $6.23M(+12.5%) | $21.38M(+6.2%) |
Mar 2022 | - | $5.54M(+17.1%) | $20.14M(+5.3%) |
Dec 2021 | $19.13M | $4.73M(-3.2%) | $19.13M(+3.5%) |
Sep 2021 | - | $4.88M(-2.1%) | $18.47M(+4.1%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Jun 2021 | - | $4.99M(+10.3%) | $17.75M(+9.7%) |
Mar 2021 | - | $4.53M(+11.1%) | $16.18M(+6.2%) |
Dec 2020 | $15.24M(+77.1%) | $4.07M(-2.0%) | $15.24M(+7.0%) |
Sep 2020 | - | $4.16M(+21.7%) | $14.25M(+13.9%) |
Jun 2020 | - | $3.42M(-4.8%) | $12.51M(+16.5%) |
Mar 2020 | - | $3.59M(+16.4%) | $10.74M(+24.9%) |
Dec 2019 | $8.61M(+353.9%) | $3.08M(+27.2%) | $8.61M(+32.3%) |
Sep 2019 | - | $2.42M(+47.0%) | $6.51M(+42.8%) |
Jun 2019 | - | $1.65M(+13.8%) | $4.56M(+44.7%) |
Mar 2019 | - | $1.45M(+47.3%) | $3.15M(+66.1%) |
Dec 2018 | $1.90M(+75.9%) | $984.00K(+107.2%) | $1.90M(+73.3%) |
Sep 2018 | - | $475.00K(+96.3%) | $1.09M(+76.7%) |
Jun 2018 | - | $242.00K(+24.1%) | $619.00K(+64.2%) |
Mar 2018 | - | $195.00K(+7.1%) | $377.00K(+107.1%) |
Dec 2017 | $1.08M | - | - |
Dec 2017 | - | $182.00K | $182.00K |
FAQ
- What is Akero Therapeutics, Inc. annual SGA?
- What is the all time high annual SGA for Akero Therapeutics, Inc.?
- What is Akero Therapeutics, Inc. annual SGA year-on-year change?
- What is Akero Therapeutics, Inc. quarterly SGA?
- What is the all time high quarterly SGA for Akero Therapeutics, Inc.?
- What is Akero Therapeutics, Inc. quarterly SGA year-on-year change?
- What is Akero Therapeutics, Inc. TTM SGA?
- What is the all time high TTM SGA for Akero Therapeutics, Inc.?
- What is Akero Therapeutics, Inc. TTM SGA year-on-year change?
What is Akero Therapeutics, Inc. annual SGA?
The current annual SGA of AKRO is $0.00
What is the all time high annual SGA for Akero Therapeutics, Inc.?
Akero Therapeutics, Inc. all-time high annual SGA is $31.07M
What is Akero Therapeutics, Inc. annual SGA year-on-year change?
Over the past year, AKRO annual SGA has changed by -$31.07M (-100.00%)
What is Akero Therapeutics, Inc. quarterly SGA?
The current quarterly SGA of AKRO is $0.00
What is the all time high quarterly SGA for Akero Therapeutics, Inc.?
Akero Therapeutics, Inc. all-time high quarterly SGA is $11.31M
What is Akero Therapeutics, Inc. quarterly SGA year-on-year change?
Over the past year, AKRO quarterly SGA has changed by -$10.42M (-100.00%)
What is Akero Therapeutics, Inc. TTM SGA?
The current TTM SGA of AKRO is -$3.45B
What is the all time high TTM SGA for Akero Therapeutics, Inc.?
Akero Therapeutics, Inc. all-time high TTM SGA is -$4.56M
What is Akero Therapeutics, Inc. TTM SGA year-on-year change?
Over the past year, AKRO TTM SGA has changed by -$3.48B (-9624.82%)